(8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one

CAS : 1207456-01-6

Ref. 3D-FF103545

Informations sur le produit

• Nom: (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one
• Synonymes: BMN673, (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one, 3H-Pyrido[4,3,2-de]phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)-, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-Pyrido[4,3,2-de]phthalazin-3-one, Bmn-673, Bmn673, Talazoparib, Talzenna

Description

Talazoparib is a small-molecule inhibitor of DNA methyltransferases (DMTs) and is currently being investigated for the treatment of platinum-resistant ovarian cancer. DMTs are enzymes that catalyze the transfer of methyl groups to the cytosine in DNA, which leads to changes in gene expression. Talazoparib has been shown to inhibit DMT1, DMT3, and DMT4 in vitro studies and was found to be minimally toxic to cultured cells and animals. This drug also exhibits anti-cancer activity by inhibiting mitochondrial membrane potential, which may lead to cell death via apoptosis or necrosis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 380.35 g/mol
• Formule: C₁₉H₁₄F₂N₆O
• Degré de pureté: Min. 95%
• Couleur/Forme: Off-White To Yellow Solid